Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

The vegan diet, rich in carbohydrates (75%) and low in fat (10%), triggered responses linked to innate immunity—the body’s ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...

Fortress Biotech (NASDAQ:FBIO)'s Chairman and CEO, Dr. Lindsay (NYSE:LNN) A. Rosenwald, expressed optimism about the vaccine's role in preventing and treating CMV in the future. While analysts ...

Pregnancy is accompanied by profound changes in the body. Among other things, these affect the energy metabolism and the ...

Maite Rodriguez and her husband gave their sick 6-year-old daughter a lifeline when their conceived a second child via IVF ...

Dr. Walker was most recently Chief Medical Officer of Harpoon Therapeutics through its acquisition by Merck in 2024 including leadership over its immune-oncology work. Prior to joining Harpoon ...

Initial data from the Phase 1 trial expected in 2025SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug is mutation-agnostic, ...

Local research and biotechnology laboratories Trudeau Institute and Ampersand Biosciences have received a $1 million grant to ...

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.